Merit Medical Systems, Inc.

Merit Medical Systems, Inc., commonly known as Merit Medical, is a medical-device manufacturer and marketer founded in 1987 by Fred Lampropoulos. The company describes its portfolio as proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures. Its products support healthcare professionals and facilities across specialties including cardiology, radiology, oncology, critical care, and endoscopy. The company serves hospitals and physicians worldwide. Merit’s broad procedural portfolio includes products and solutions for biopsy, cardiac catheterization, critical care, dialysis access, drainage, embolotherapy, electrophysiology and cardiac rhythm management, gastroenterology, vascular access, and other clinical applications. The company also provides product resources, procedural information, clinical education opportunities, and patient-awareness materials through its website. Merit presents customer focus and patient care as central to its corporate identity. Its stated vision is to be the most customer-focused company in healthcare, and it describes its mission as “Understand. Innovate. Deliver.” The company’s published values, known as The Merit Way, are organized around health, excellence, agility, responsibility, and teamwork. Merit also reports on environmental, social, and governance priorities and publishes sustainability reports. Merit is based in South Jordan, Utah, and operates internationally, with a domestic and international sales force and clinical support team. The company is publicly traded under the ticker MMSI. Its official About page reports a workforce of approximately 7,500 people worldwide, while the homepage gives an earlier figure of approximately 7,000; these are presented as source-reported figures rather than a single fixed headcount.

Merit Medical Systems, Inc. was founded in 1987 by Fred Lampropoulos. From its beginning, the company’s business has centered on manufacturing and marketing proprietary disposable medical devices. Its products are intended for use in interventional, diagnostic, and therapeutic procedures, placing the company within the medical-technology sector and connecting its work to a range of hospital-based specialties. Merit’s portfolio and procedural scope have developed across areas such as cardiology, radiology, oncology, critical care, and endoscopy. The company’s current official website lists solutions for biopsy, cardiac catheterization, critical care, dialysis access, drainage, embolotherapy, electrophysiology and cardiac rhythm management, gastroenterology, radial access, and venous procedures, among other applications. The breadth of these categories reflects a strategy of serving clinical workflows across multiple specialties rather than focusing on a single device category. Merit also makes product resources and procedural information available to healthcare professionals, alongside clinical education and patient-awareness opportunities. The company has built an international customer base. Its official About page says it serves hospitals worldwide through domestic and international sales and clinical-support teams. The company has described its global workforce at different approximate levels on its official pages: the homepage states approximately 7,000 employees, while the About page reports approximately 7,500. These figures should be understood as page-specific estimates, not as evidence of a precise dated change in headcount. Merit’s corporate messaging emphasizes understanding customer needs, innovation, and delivery. Its stated vision is to become the most customer-focused company in healthcare. In 2024, the company launched The Merit Way, a set of core values intended to guide how employees behave and how work is done. The values are represented by the acronym H.E.A.R.T.: Health, Excellence, Agility, Responsibility, and Teamwork. The company describes this culture initiative as honoring its history while setting expectations for its future. Its sustainability program also includes environmental, social, and governance priorities and a series of sustainability reports. The official sustainability page describes a transition from a founder-led to a founder-inspired culture and identifies Fred Lampropoulos as the founder. Merit’s publicly stated account therefore links its origins to the founder while presenting its current culture as an organizational framework intended to carry the company forward. The available evidence establishes the founding year, founder, product focus, global reach, values initiative, and sustainability reporting, but does not establish a complete chronology of acquisitions, listing events, leadership transitions, or individual product-launch dates. Merit is an active medical-device business and trades publicly under the ticker MMSI.

• 2024

  The Merit Way launched

• 1987

  Merit Medical Systems founded

A global medical-device manufacturer focused on proprietary disposable devices and procedural solutions for hospitals, physicians, and other healthcare professionals. The company emphasizes customer focus, innovation, clinical support, and products intended to support positive patient outcomes.

• Biopsy Solutions

  A product category listed by Merit for biopsy procedures.

• Cardiac Catheterization

  A product and procedural-solution category listed by Merit.

• Embolotherapy

  A product category in Merit’s procedural portfolio.

• Dialysis Access

  A product category listed on Merit’s official website.

• Radial Access

  A product category listed on Merit’s official website.

• 2024

  Introduced The Merit WayOther

• 2026-10-13

  Merit Medical Systems completes acquisition of Solo Pace[6]Merit Medical Systems完成对Solo Pace的收购rttnews.com

  Reported: 2026-10-30

  Merit Medical Systems acquired the remaining shares of Solo Pace, a Minneapolis-based manufacturer of temporary pacing systems, for approximately $45 million.

• Unconfirmed

  Freudenberg Medical acquires Merit Medical’s hypotube manufacturing assets[7]Freudenberg Medical收购Merit Medical的微管制造资产finanznachrichten.de

  Reported: 2020-09-08

  Freudenberg Medical acquired the dedicated manufacturing equipment and associated assets used by Merit Medical Systems in its hypotube manufacturing business. The assets will be absorbed by Cambus Medical.

1. 1Merit Medical Systems | Global Medical Device Innovationmerit.com
2. 2About Merit Medical | Understand. Innovate. Deliver.merit.com
3. 3Corporate Sustainability from Merit Medicalmerit.com
4. 4Diversity & Talent - Understand Innovate Deliver - Merit Medicalmerit.com
5. 5Merit Medical (United States)wikidata.org
6. 6Merit Medical Systems完成对Solo Pace的收购rttnews.com
7. 7Freudenberg Medical收购Merit Medical的微管制造资产finanznachrichten.de